Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Importance The increasing use of neoadjuvant chemotherapy (NAC) for operable breast
cancer has raised questions about optimal local therapy for the axilla. Observations Sentinel …

Introduction In patients with positive lymph nodes (cN+) prior to neoadjuvant treatment
(NAT), which convert to a clinically negative axilla (cN0) after treatment, the use of sentinel …

Neoadjuvant treatment of breast cancer has become established as the safe and often
effective therapeutic approach of choice for larger primary and for locally advanced breast …

BACKGROUND The use of sentinel lymph node biopsy (SLNB) following neoadjuvant
chemotherapy (NAC) in patients presenting with clinically positive lymph nodes remains …

The treatment of breast cancer has evolved from a primary surgical approach with a focus on
local-regional control to multidisciplinary management with an emphasis on systemic …

Background With the increased use of neoadjuvant chemotherapy (NAC) in breast cancer,
the timing of sentinel lymph node biopsy (SLNB) has become increasingly important. In this …

Sentinel lymph node biopsy has become a standard staging tool in the surgical
management of breast cancer. The positive impact of sentinel lymph node biopsy on …

The increased use of neoadjuvant chemotherapy (NACT) has changed the approach to
breast surgery. NACT allows de-escalation of surgery by both increasing breast …

Purpose Neoadjuvant chemotherapy (NACT) is increasingly adopted in the therapy of breast
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …